Canopus BioPharma Incorporated
CBIA · OTC
5/31/2023 | 2/28/2023 | 11/30/2022 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | $16,137 | $11,380 | $4,884 | $12,373 |
| - Cash | $6 | $3 | $4 | $8 |
| + Debt | $184 | $10 | $10 | $10 |
| Enterprise Value | $16,315 | $11,388 | $4,890 | $12,375 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$190 | -$783 | -$4 | -$425 |
| % Margin | – | – | – | – |
| Net Income | -$204 | -$783 | -$4 | -$425 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.006 | -0 | -0.003 |
| % Growth | 75.8% | -20,260.5% | 99.1% | – |
| Operating Cash Flow | -$157 | -$1 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$157 | -$1 | -$1 | -$0 |